Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY26.27 CNY
Change Today +1.16 / 4.62%
Volume 14.7M
As of 3:05 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

tianjin zhong xin pharm co-a (600329) Snapshot

Open
CNY25.50
Previous Close
CNY25.11
Day High
CNY26.45
Day Low
CNY25.04
52 Week High
05/22/15 - CNY26.45
52 Week Low
05/26/14 - CNY13.35
Market Cap
16.0B
Average Volume 10 Days
13.8M
EPS TTM
CNY0.51
Shares Outstanding
539.3M
EX-Date
06/1/15
P/E TM
51.9x
Dividend
CNY0.15
Dividend Yield
0.19%
Current Stock Chart for TIANJIN ZHONG XIN PHARM CO-A (600329)

Related News

No related news articles were found.

tianjin zhong xin pharm co-a (600329) Related Businessweek News

No Related Businessweek News Found

tianjin zhong xin pharm co-a (600329) Details

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, an investment holding company, produces and sells traditional Chinese medicines, western medicines, and healthcare products primarily in the People's Republic of China. It offers Chinese patent medicines, Chinese medicinal materials, pharmaceutical raw materials and western medicines, bioengineering drugs, nutritious and health products, etc. The company’s principal products include Suxiao Jiuxin Wan, Huoxiang Zhengqi Ruan Jiaonang, Zilong Jin Pian, Jinqi Jiangtang Pian, Weichang An Wan, Biqi Jiaonang, a-2b Interferon, Gliclazide, Te Zi She Fu, etc. It is also involved in the wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products. In addition, the company sells medicinal products under its own brand and other brands to wholesalers. Tianjin Zhong Xin Pharmaceutical Group Corporation Limited was founded in 1992 and is based in Tianjin, the People's Republic of China.

Founded in 1992

tianjin zhong xin pharm co-a (600329) Top Compensated Officers

Executive Chairman, General Manager and Chair...
Total Annual Compensation: CNY1.0M
Executive Director
Total Annual Compensation: CNY757.3K
Chief Engineer, Deputy General Manager, Execu...
Total Annual Compensation: CNY500.0K
Compensation as of Fiscal Year 2013.

tianjin zhong xin pharm co-a (600329) Key Developments

Tianjin Zhongxin Pharmaceutical Group Corporation Limited Announces Final Dividend for the Year Ended December 31, 2014, Payable on or About June 12, 2015

Tianjin Zhongxin Pharmaceutical Group Corporation Limited announced final dividend of RMB 15 cents per ordinary Share for the year ended December 31, 2014. The final dividend, which was approved by shareholders of the company at the company's annual general meeting held on 15 May 2015. Shareholders whose securities accounts with The Central Depository (Pte) Limited are credited with Shares as at 5.00 p.m. on 26 May 2015 will be entitled to the Final Dividend. The Final Dividend is expected to be paid on or about 12 June 2015.

Tianjin Zhong Xin Pharm Group Announces Appointment of Mr. Wang Lei as Executive Director

On May 15, 2015, Tianjin Zhong Xin Pharm Group announced the appointment of Mr. Wang Lei as executive director of the company, he will be a member of audit committee and the strategy committee and the chairman of the nomination committee. For the period from March 2001 to April 2004 she was firstly appointed as deputy director of planning division and then as the deputy director of industry department in the company. From June 2014 to present, she is working as the deputy general manager of the company.

Tianjin Zhong Xin Pharm Group Appoints Qiang Zhi Yuan Min as Non-Executive Independent Director, Member of Audit Committee, Strategy Committee and Chairman of the Nomination Committee

On May 15, 2015, Tianjin Zhong Xin Pharm Group announced the appointment of Mr. Qiang Zhi Yuan Min as non-executive independent director of the company, he will be a member of audit committee and the strategy committee and the chairman of the nomination committee. He was also the former director and former deputy director of economics research centre of Tianjin University of Finance and Economics, the vice president, president and vice Chairman of Tianjin Northern Talent Co. Ltd. From June 2009 to May 2014, he worked as the dean in Graduate School of Modern Economics Management of Tianjin University of Finance and Economics. From June 2014 to present, he is working as the professor in Graduate School of Modern Economics Management of Tianjin University of Finance and Economics.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600329:CH CNY26.27 CNY +1.16

600329 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
American Oriental Bioengineering Inc $3.85 USD 0.00
View Industry Companies
 

Industry Analysis

600329

Industry Average

Valuation 600329 Industry Range
Price/Earnings 52.5x
Price/Sales 2.7x
Price/Book 6.7x
Price/Cash Flow 37.8x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANJIN ZHONG XIN PHARM CO-A, please visit www.zhongxinp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.